ESR1 and breast cancer: Therefore, it is meaningful to transfer the wild type ERα into basal-like breast cancer to verify the genome wide changes, which may provide important information for unknown mechanisms that contribute to breast cancer subtype and sheds light on clinical therapeutic for patients with basal-like breast cancers.